GlassScriptPhysician profile
Daniela Garcia
NPI 1669833612
$2,492.54
in general payments reported to CMS, 2019-2025
22 companies · $473 in 2025
The $473 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $511 · 2022: $284 · 2023: $995 · 2024: $230 · 2025: $473.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,697.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $650.79 | 2021-2025 | Farxiga, Lokelma |
| Nevro Corp. | $356.31 | 2023-2024 | Senza |
| Lilly USA, LLC | $294.84 | 2021-2025 | Mounjaro, Trulicity, Zepbound |
| Glaxosmithkline, LLC. | $136.93 | 2023 | Benlysta, Arexvy, Trelegy Ellipta |
| Abbvie INC. | $128.29 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $125.00 | 2022 | |
| Dexcom, INC. | $115.54 | 2025 | Dexcom G6 Transmitter |
| Janssen Pharmaceuticals, INC | $104.48 | 2021 | |
| Sage Therapeutics, LLC | $100.00 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $88.10 | 2023-2024 | Rexulti |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $80.80 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.39 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $41.39 | 2021 | |
| Exact Sciences Corporation | $39.51 | 2024-2025 | Cologuard Collection Kit |
| Pfizer INC. | $38.67 | 2021-2025 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $38.14 | 2025 | Wegovy, Ozempic, Rybelsus |
| Abbott Laboratories | $23.26 | 2022 | |
| Sanofi Pasteur INC. | $20.45 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $20.26 | 2023 | Sotyktu |
| Amgen INC. | $13.89 | 2022 | |
| Biogen, INC. | $13.89 | 2021 | |
| Genentech USA, INC. | $0.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.